Video

Physician-Scientist Marco Davila, MD, PhD, Joins Growing Roswell Park Cellular Therapy Program

Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.

Video

Reaching Deep Remissions with a New Therapy for Multiple Myeloma Patients

Roswell Park is spearheading efforts to study innovative CAR T-cell therapies in addition to offering traditional treatment approaches.

Video

Neurological Effects of Immunotherapy

While immunotherapies are changing the way oncologists treat their patients, these new therapies are not entirely without side effects. Chinazom Ibegbu, MD, Assistant Professor of Oncology and neuro-oncologist at Roswell Park Comprehensive ...

Video

Is Your Patient Immunocompromised?

Director of the Transplant & Cellular Therapy Center at Roswell Park Comprehensive Cancer Center, Phillip McCarthy, MD, discusses protocols in place to ensure the safety of our most vulnerable patient population. Dr. McCarthy also reviews ...

Video

Managing Toxicities of Immunotherapy

Igor Puzanov, MD, MSCI, FACP, is an expert in the management of immunotherapy toxicities. In this video presentation, he shares vital information for physicians who care for patients undergoing immunotherapy treatment.

Video

Fundamentals of Cancer Immunotherapy

Gurkamal Chatta, MD, Clinical Chief of Genitourinary Medicine, presents on immuno-oncology, new immunotherapy cancer treatments and how the immune system responds to cancer.

News

Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy.

News

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

At Roswell Park Comprehensive Cancer Center, Philip McCarthy, MD, Director of the Transplant and Cellular Therapy Center in the Department of Medicine, and a multidisciplinary team of colleagues recently undertook a study to understand ...

News

New Roswell Park Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

Many of the most aggressive and hard-to-treat cancers are highly effective at blocking T cells, known as the foot soldiers of the immune system, from reaching and responding to tumors. It’s a cancer defense mechanism that even groundbreaking ...